Trials / Sponsors / Aardvark Therapeutics, Inc.
Aardvark Therapeutics, Inc.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Suspended | ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective Trial Hyperphagia, Prader-Willi Syndrome | Phase 3 | 2024-12-20 |
| Completed | A Study to Evaluate ARD-501 in Patients With Autism Spectrum Disorder Autism Spectrum Disorder | Phase 2 | 2024-08-01 |
| Suspended | The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) Trial Hyperphagia, Prader-Willi Syndrome, Hyperphagia in Prader-Willi Syndrome | Phase 3 | 2024-07-23 |
| Completed | A Study of Oral ARD-101 in Patients With Prader-Willi Syndrome Prader-Willi Syndrome | Phase 2 | 2022-05-27 |
| Completed | Study to Evaluate ARD-101 in Adults Receiving Bariatric Surgery Bariatric Surgery, Obesity, Weight Gain | Phase 2 | 2022-03-01 |
| Completed | Study to Evaluate ARD-101 in Adults With Obesity Obesity | Phase 2 | 2021-11-15 |